-
WASHINGTON - Women who are past menopause and healthy should not take hormone replacement therapy in hopes of warding off dementia, bone fractures or heart disease, says a new analysis by the government task force that weighs the risks and benefits of screening and other therapies aimed at preventing illness.
The recommendation by the U.S. Preventive Services Task Force does not necessarily apply to women who take hormone replacement therapy to reduce menopausal symptoms such as hot flashes, night sweats and vaginal dryness. The balance of harms and benefits for that use is expected to be addressed in an imminent report by the federal government's Office of Health Quality Research.
-
With Pfizer and plaintiffs' lawyers squabbling over who has won the most hormone replacement therapy trials, only one thing about the litigation is clear: It's turning into one of the longest- running mass torts in U.S. history.
I believe that this is now the longest-running MDL with no inventory settlements and no mass settlements in sight," said Zoe Littlepage, a partner at Littlepage Booth in Houston and lead plaintiffs' counsel in the federal multi-district litigation.
-
Findings Announced at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting
CARLSBAD, Calif., July 30 /PRNewswire-USNewswire/ -- Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against the formation and/or rupture of brain aneurysms - balloon-like sacks that form in a weakened artery wall and, upon bursting, can cause severe disability or death. The study represents one of 130 abstracts submitted to SNIS for consideration for presentation at what has become the premier scientific forum ...
-
-
With age comes wisdom. And for many women, age also brings hot flashes, vaginal dryness and moodiness. This is menopause, the time in a woman's life when her menstrual periods stop. That's something many women would look forward to if the change were swift and uneventful. Alas, that is not usually the case.
During perimenopause (the time leading up to menopause) and menopause, women may experience hot flashes, moodiness, sleep disturbances, declining sexual desire and weight change. Declining levels of estrogen, along with other hormonal changes, are usually responsible for the discomfort women suffer.
-
Proceedings have started in the latest bellwether trial in hormone replacement therapy mass tort litigation in state court in Pennsylvania.
Cheryl Foust, 56, of Abingdon, Ind., died in 2005 after taking Prempro from 1999 until 2003, when she was diagnosed with breast cancer.
-
Pfizer is entitled to a new trial in a hormone replacement therapy drug suit, a trial court judge in Pennsylvania has ruled.
Merle Simon developed breast cancer after taking Provera (manufactured by Upjohn, which was subsequently purchased by Pfizer) for approximately ten years as part of a hormone replacement therapy program.
-
A look at some of the major sectors in the anti-aging industry:
Hormone replacement therapy
-
Search Over 18,000 People and Over 1,000 Hormone Replacement Therapy Research Organisations
DUBLIN -- Maven Semantic (http://www.mavensemantic.com) a...
-
Women who take hormone replacement drugs have good reason to do so. The hormones relieve or eliminate menopausal symptoms such as hot flashes and mood irregularities as well as slow bone loss. But the decision to take the hormones has become far more complicated since a 2002 study of one of the most popular hormone drugs, Prempro, found that those taking it had a slight increase of breast cancer as well as stroke, heart attack and blood clots. Sales of the drug dropped by half as millions of women stopped hormone replacement therapy.
The following year, something remarkable happened, according to an analysis of breast cancer statistics by researchers at the M.D. Anderson Cancer Center in Houston. Although the incidence of breast cancer has been steadily increasing for decades, in 2003 i...